Keytruda sales power Merck to quarterly beat

(Reuters) – Drugmaker Merck & Co reported a better-than-expected first-quarter profit on Tuesday, helped by a more than 150 percent rise in sales of cancer drug Keytruda.

Powered by WPeMatico

Scroll to top